ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ciclosporin Soft Capsules Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30V14433
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ciclosporin Soft Capsules Market Research Report 2023
BUY CHAPTERS

Global Ciclosporin Soft Capsules Market Research Report 2025

Code: QYRE-Auto-30V14433
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
North China Pharmaceutical Co., Ltd
Hainan Haishen Tongzhou Pharmaceutical Co., Ltd.
Zhejiang Ruibang Laboratories
Catalent Germany Eberbach GmbH
The Central Pharmaceutical Co.,Ltd.
Shanghai Donghai Pharmaceutical Co., Ltd.
Lizhu Group Lizhu Pharmaceutical Factory
Wuxi Shuhui Pharmaceutical Co., Ltd.
Anshi Pharmaceutical(Zhongshan)Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd.
Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.

Ciclosporin Soft Capsules Market

The global market for Ciclosporin Soft Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cyclosporin soft capsule is a potent immunosuppressant that can prolong the survival time of allografts and suppress humoral immunity and cell-mediated reactions.
North American market for Ciclosporin Soft Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Ciclosporin Soft Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Ciclosporin Soft Capsules include Catalent Germany Eberbach GmbH, North China Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co.,Ltd., Beijing SL Pharmaceutical Co.,Ltd., Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd., The Central Pharmaceutical Co.,Ltd., Shanghai Donghai Pharmaceutical Co., Ltd., Lizhu Group Lizhu Pharmaceutical Factory, Hainan Haishen Tongzhou Pharmaceutical Co.Ltd., Wuxi Shuhui Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ciclosporin Soft Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ciclosporin Soft Capsules.
The Ciclosporin Soft Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ciclosporin Soft Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ciclosporin Soft Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ciclosporin Soft Capsules Market Report

Report Metric Details
Report Name Ciclosporin Soft Capsules Market
Segment by Type
  • 10mg
  • 25mg
  • 50mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Catalent Germany Eberbach GmbH, North China Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co.,Ltd., Beijing SL Pharmaceutical Co.,Ltd., Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd., The Central Pharmaceutical Co.,Ltd., Shanghai Donghai Pharmaceutical Co., Ltd., Lizhu Group Lizhu Pharmaceutical Factory, Hainan Haishen Tongzhou Pharmaceutical Co.Ltd., Wuxi Shuhui Pharmaceutical Co., Ltd., Zhejiang Ruibang Laboratories, Anshi Pharmaceutical(Zhongshan)Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ciclosporin Soft Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ciclosporin Soft Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Ciclosporin Soft Capsules Market report?

Ans: The main players in the Ciclosporin Soft Capsules Market are Catalent Germany Eberbach GmbH, North China Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co.,Ltd., Beijing SL Pharmaceutical Co.,Ltd., Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd., The Central Pharmaceutical Co.,Ltd., Shanghai Donghai Pharmaceutical Co., Ltd., Lizhu Group Lizhu Pharmaceutical Factory, Hainan Haishen Tongzhou Pharmaceutical Co.Ltd., Wuxi Shuhui Pharmaceutical Co., Ltd., Zhejiang Ruibang Laboratories, Anshi Pharmaceutical(Zhongshan)Inc.

What are the Application segmentation covered in the Ciclosporin Soft Capsules Market report?

Ans: The Applications covered in the Ciclosporin Soft Capsules Market report are Hospital, Clinic, Retail Pharmacy, Others

What are the Type segmentation covered in the Ciclosporin Soft Capsules Market report?

Ans: The Types covered in the Ciclosporin Soft Capsules Market report are 10mg, 25mg, 50mg

Recommended Reports

Soft Capsule Markets

Capsule Equipment

Supplement & Packaging

1 Ciclosporin Soft Capsules Market Overview
1.1 Product Definition
1.2 Ciclosporin Soft Capsules by Type
1.2.1 Global Ciclosporin Soft Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 10mg
1.2.3 25mg
1.2.4 50mg
1.3 Ciclosporin Soft Capsules by Application
1.3.1 Global Ciclosporin Soft Capsules Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacy
1.3.5 Others
1.4 Global Ciclosporin Soft Capsules Market Size Estimates and Forecasts
1.4.1 Global Ciclosporin Soft Capsules Revenue 2020-2031
1.4.2 Global Ciclosporin Soft Capsules Sales 2020-2031
1.4.3 Global Ciclosporin Soft Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ciclosporin Soft Capsules Market Competition by Manufacturers
2.1 Global Ciclosporin Soft Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ciclosporin Soft Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ciclosporin Soft Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ciclosporin Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ciclosporin Soft Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ciclosporin Soft Capsules, Product Type & Application
2.7 Global Key Manufacturers of Ciclosporin Soft Capsules, Date of Enter into This Industry
2.8 Global Ciclosporin Soft Capsules Market Competitive Situation and Trends
2.8.1 Global Ciclosporin Soft Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ciclosporin Soft Capsules Players Market Share by Revenue
2.8.3 Global Ciclosporin Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ciclosporin Soft Capsules Market Scenario by Region
3.1 Global Ciclosporin Soft Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ciclosporin Soft Capsules Sales by Region: 2020-2031
3.2.1 Global Ciclosporin Soft Capsules Sales by Region: 2020-2025
3.2.2 Global Ciclosporin Soft Capsules Sales by Region: 2026-2031
3.3 Global Ciclosporin Soft Capsules Revenue by Region: 2020-2031
3.3.1 Global Ciclosporin Soft Capsules Revenue by Region: 2020-2025
3.3.2 Global Ciclosporin Soft Capsules Revenue by Region: 2026-2031
3.4 North America Ciclosporin Soft Capsules Market Facts & Figures by Country
3.4.1 North America Ciclosporin Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ciclosporin Soft Capsules Sales by Country (2020-2031)
3.4.3 North America Ciclosporin Soft Capsules Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ciclosporin Soft Capsules Market Facts & Figures by Country
3.5.1 Europe Ciclosporin Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ciclosporin Soft Capsules Sales by Country (2020-2031)
3.5.3 Europe Ciclosporin Soft Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ciclosporin Soft Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Ciclosporin Soft Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ciclosporin Soft Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Ciclosporin Soft Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ciclosporin Soft Capsules Market Facts & Figures by Country
3.7.1 Latin America Ciclosporin Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ciclosporin Soft Capsules Sales by Country (2020-2031)
3.7.3 Latin America Ciclosporin Soft Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ciclosporin Soft Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Ciclosporin Soft Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ciclosporin Soft Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ciclosporin Soft Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ciclosporin Soft Capsules Sales by Type (2020-2031)
4.1.1 Global Ciclosporin Soft Capsules Sales by Type (2020-2025)
4.1.2 Global Ciclosporin Soft Capsules Sales by Type (2026-2031)
4.1.3 Global Ciclosporin Soft Capsules Sales Market Share by Type (2020-2031)
4.2 Global Ciclosporin Soft Capsules Revenue by Type (2020-2031)
4.2.1 Global Ciclosporin Soft Capsules Revenue by Type (2020-2025)
4.2.2 Global Ciclosporin Soft Capsules Revenue by Type (2026-2031)
4.2.3 Global Ciclosporin Soft Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Ciclosporin Soft Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ciclosporin Soft Capsules Sales by Application (2020-2031)
5.1.1 Global Ciclosporin Soft Capsules Sales by Application (2020-2025)
5.1.2 Global Ciclosporin Soft Capsules Sales by Application (2026-2031)
5.1.3 Global Ciclosporin Soft Capsules Sales Market Share by Application (2020-2031)
5.2 Global Ciclosporin Soft Capsules Revenue by Application (2020-2031)
5.2.1 Global Ciclosporin Soft Capsules Revenue by Application (2020-2025)
5.2.2 Global Ciclosporin Soft Capsules Revenue by Application (2026-2031)
5.2.3 Global Ciclosporin Soft Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Ciclosporin Soft Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Catalent Germany Eberbach GmbH
6.1.1 Catalent Germany Eberbach GmbH Company Information
6.1.2 Catalent Germany Eberbach GmbH Description and Business Overview
6.1.3 Catalent Germany Eberbach GmbH Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Catalent Germany Eberbach GmbH Ciclosporin Soft Capsules Product Portfolio
6.1.5 Catalent Germany Eberbach GmbH Recent Developments/Updates
6.2 North China Pharmaceutical Co., Ltd.
6.2.1 North China Pharmaceutical Co., Ltd. Company Information
6.2.2 North China Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 North China Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 North China Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Product Portfolio
6.2.5 North China Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Shenzhen Salubris Pharmaceuticals Co.,Ltd.
6.3.1 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Information
6.3.2 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Description and Business Overview
6.3.3 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Ciclosporin Soft Capsules Product Portfolio
6.3.5 Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Developments/Updates
6.4 Beijing SL Pharmaceutical Co.,Ltd.
6.4.1 Beijing SL Pharmaceutical Co.,Ltd. Company Information
6.4.2 Beijing SL Pharmaceutical Co.,Ltd. Description and Business Overview
6.4.3 Beijing SL Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beijing SL Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Product Portfolio
6.4.5 Beijing SL Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.5 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.
6.5.1 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Company Information
6.5.2 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Description and Business Overview
6.5.3 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Ciclosporin Soft Capsules Product Portfolio
6.5.5 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Recent Developments/Updates
6.6 The Central Pharmaceutical Co.,Ltd.
6.6.1 The Central Pharmaceutical Co.,Ltd. Company Information
6.6.2 The Central Pharmaceutical Co.,Ltd. Description and Business Overview
6.6.3 The Central Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 The Central Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Product Portfolio
6.6.5 The Central Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.7 Shanghai Donghai Pharmaceutical Co., Ltd.
6.7.1 Shanghai Donghai Pharmaceutical Co., Ltd. Company Information
6.7.2 Shanghai Donghai Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Shanghai Donghai Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanghai Donghai Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Product Portfolio
6.7.5 Shanghai Donghai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Lizhu Group Lizhu Pharmaceutical Factory
6.8.1 Lizhu Group Lizhu Pharmaceutical Factory Company Information
6.8.2 Lizhu Group Lizhu Pharmaceutical Factory Description and Business Overview
6.8.3 Lizhu Group Lizhu Pharmaceutical Factory Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Lizhu Group Lizhu Pharmaceutical Factory Ciclosporin Soft Capsules Product Portfolio
6.8.5 Lizhu Group Lizhu Pharmaceutical Factory Recent Developments/Updates
6.9 Hainan Haishen Tongzhou Pharmaceutical Co.Ltd.
6.9.1 Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Company Information
6.9.2 Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Description and Business Overview
6.9.3 Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Ciclosporin Soft Capsules Product Portfolio
6.9.5 Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Recent Developments/Updates
6.10 Wuxi Shuhui Pharmaceutical Co., Ltd.
6.10.1 Wuxi Shuhui Pharmaceutical Co., Ltd. Company Information
6.10.2 Wuxi Shuhui Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Wuxi Shuhui Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Wuxi Shuhui Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Product Portfolio
6.10.5 Wuxi Shuhui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Zhejiang Ruibang Laboratories
6.11.1 Zhejiang Ruibang Laboratories Company Information
6.11.2 Zhejiang Ruibang Laboratories Description and Business Overview
6.11.3 Zhejiang Ruibang Laboratories Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhejiang Ruibang Laboratories Ciclosporin Soft Capsules Product Portfolio
6.11.5 Zhejiang Ruibang Laboratories Recent Developments/Updates
6.12 Anshi Pharmaceutical(Zhongshan)Inc.
6.12.1 Anshi Pharmaceutical(Zhongshan)Inc. Company Information
6.12.2 Anshi Pharmaceutical(Zhongshan)Inc. Description and Business Overview
6.12.3 Anshi Pharmaceutical(Zhongshan)Inc. Ciclosporin Soft Capsules Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Anshi Pharmaceutical(Zhongshan)Inc. Ciclosporin Soft Capsules Product Portfolio
6.12.5 Anshi Pharmaceutical(Zhongshan)Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ciclosporin Soft Capsules Industry Chain Analysis
7.2 Ciclosporin Soft Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ciclosporin Soft Capsules Production Mode & Process Analysis
7.4 Ciclosporin Soft Capsules Sales and Marketing
7.4.1 Ciclosporin Soft Capsules Sales Channels
7.4.2 Ciclosporin Soft Capsules Distributors
7.5 Ciclosporin Soft Capsules Customer Analysis
8 Ciclosporin Soft Capsules Market Dynamics
8.1 Ciclosporin Soft Capsules Industry Trends
8.2 Ciclosporin Soft Capsules Market Drivers
8.3 Ciclosporin Soft Capsules Market Challenges
8.4 Ciclosporin Soft Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
North China Pharmaceutical Co., Ltd
Hainan Haishen Tongzhou Pharmaceutical Co., Ltd.
Zhejiang Ruibang Laboratories
Catalent Germany Eberbach GmbH
The Central Pharmaceutical Co.,Ltd.
Shanghai Donghai Pharmaceutical Co., Ltd.
Lizhu Group Lizhu Pharmaceutical Factory
Wuxi Shuhui Pharmaceutical Co., Ltd.
Anshi Pharmaceutical(Zhongshan)Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd.
Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.
List of Tables
 Table 1. Global Ciclosporin Soft Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ciclosporin Soft Capsules Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ciclosporin Soft Capsules Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ciclosporin Soft Capsules Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ciclosporin Soft Capsules Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ciclosporin Soft Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ciclosporin Soft Capsules Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ciclosporin Soft Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ciclosporin Soft Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ciclosporin Soft Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ciclosporin Soft Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Ciclosporin Soft Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ciclosporin Soft Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ciclosporin Soft Capsules as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ciclosporin Soft Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ciclosporin Soft Capsules Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ciclosporin Soft Capsules Sales Market Share by Region (2020-2025)
 Table 19. Global Ciclosporin Soft Capsules Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ciclosporin Soft Capsules Sales Market Share by Region (2026-2031)
 Table 21. Global Ciclosporin Soft Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ciclosporin Soft Capsules Revenue Market Share by Region (2020-2025)
 Table 23. Global Ciclosporin Soft Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ciclosporin Soft Capsules Revenue Market Share by Region (2026-2031)
 Table 25. North America Ciclosporin Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ciclosporin Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ciclosporin Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ciclosporin Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ciclosporin Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ciclosporin Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ciclosporin Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ciclosporin Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ciclosporin Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ciclosporin Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ciclosporin Soft Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ciclosporin Soft Capsules Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ciclosporin Soft Capsules Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ciclosporin Soft Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ciclosporin Soft Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ciclosporin Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ciclosporin Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ciclosporin Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ciclosporin Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ciclosporin Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ciclosporin Soft Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ciclosporin Soft Capsules Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ciclosporin Soft Capsules Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ciclosporin Soft Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ciclosporin Soft Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ciclosporin Soft Capsules Sales (K Units) by Type (2020-2025)
 Table 51. Global Ciclosporin Soft Capsules Sales (K Units) by Type (2026-2031)
 Table 52. Global Ciclosporin Soft Capsules Sales Market Share by Type (2020-2025)
 Table 53. Global Ciclosporin Soft Capsules Sales Market Share by Type (2026-2031)
 Table 54. Global Ciclosporin Soft Capsules Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ciclosporin Soft Capsules Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ciclosporin Soft Capsules Revenue Market Share by Type (2020-2025)
 Table 57. Global Ciclosporin Soft Capsules Revenue Market Share by Type (2026-2031)
 Table 58. Global Ciclosporin Soft Capsules Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ciclosporin Soft Capsules Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ciclosporin Soft Capsules Sales (K Units) by Application (2020-2025)
 Table 61. Global Ciclosporin Soft Capsules Sales (K Units) by Application (2026-2031)
 Table 62. Global Ciclosporin Soft Capsules Sales Market Share by Application (2020-2025)
 Table 63. Global Ciclosporin Soft Capsules Sales Market Share by Application (2026-2031)
 Table 64. Global Ciclosporin Soft Capsules Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ciclosporin Soft Capsules Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ciclosporin Soft Capsules Revenue Market Share by Application (2020-2025)
 Table 67. Global Ciclosporin Soft Capsules Revenue Market Share by Application (2026-2031)
 Table 68. Global Ciclosporin Soft Capsules Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ciclosporin Soft Capsules Price (US$/Unit) by Application (2026-2031)
 Table 70. Catalent Germany Eberbach GmbH Company Information
 Table 71. Catalent Germany Eberbach GmbH Description and Business Overview
 Table 72. Catalent Germany Eberbach GmbH Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Catalent Germany Eberbach GmbH Ciclosporin Soft Capsules Product
 Table 74. Catalent Germany Eberbach GmbH Recent Developments/Updates
 Table 75. North China Pharmaceutical Co., Ltd. Company Information
 Table 76. North China Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. North China Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. North China Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Product
 Table 79. North China Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Company Information
 Table 81. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Description and Business Overview
 Table 82. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Ciclosporin Soft Capsules Product
 Table 84. Shenzhen Salubris Pharmaceuticals Co.,Ltd. Recent Developments/Updates
 Table 85. Beijing SL Pharmaceutical Co.,Ltd. Company Information
 Table 86. Beijing SL Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 87. Beijing SL Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Beijing SL Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Product
 Table 89. Beijing SL Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 90. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Company Information
 Table 91. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Description and Business Overview
 Table 92. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Ciclosporin Soft Capsules Product
 Table 94. Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Recent Developments/Updates
 Table 95. The Central Pharmaceutical Co.,Ltd. Company Information
 Table 96. The Central Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 97. The Central Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. The Central Pharmaceutical Co.,Ltd. Ciclosporin Soft Capsules Product
 Table 99. The Central Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 100. Shanghai Donghai Pharmaceutical Co., Ltd. Company Information
 Table 101. Shanghai Donghai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Shanghai Donghai Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shanghai Donghai Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Product
 Table 104. Shanghai Donghai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Lizhu Group Lizhu Pharmaceutical Factory Company Information
 Table 106. Lizhu Group Lizhu Pharmaceutical Factory Description and Business Overview
 Table 107. Lizhu Group Lizhu Pharmaceutical Factory Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Lizhu Group Lizhu Pharmaceutical Factory Ciclosporin Soft Capsules Product
 Table 109. Lizhu Group Lizhu Pharmaceutical Factory Recent Developments/Updates
 Table 110. Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Company Information
 Table 111. Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Description and Business Overview
 Table 112. Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Ciclosporin Soft Capsules Product
 Table 114. Hainan Haishen Tongzhou Pharmaceutical Co.Ltd. Recent Developments/Updates
 Table 115. Wuxi Shuhui Pharmaceutical Co., Ltd. Company Information
 Table 116. Wuxi Shuhui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Wuxi Shuhui Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Wuxi Shuhui Pharmaceutical Co., Ltd. Ciclosporin Soft Capsules Product
 Table 119. Wuxi Shuhui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Zhejiang Ruibang Laboratories Company Information
 Table 121. Zhejiang Ruibang Laboratories Description and Business Overview
 Table 122. Zhejiang Ruibang Laboratories Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Zhejiang Ruibang Laboratories Ciclosporin Soft Capsules Product
 Table 124. Zhejiang Ruibang Laboratories Recent Developments/Updates
 Table 125. Anshi Pharmaceutical(Zhongshan)Inc. Company Information
 Table 126. Anshi Pharmaceutical(Zhongshan)Inc. Description and Business Overview
 Table 127. Anshi Pharmaceutical(Zhongshan)Inc. Ciclosporin Soft Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Anshi Pharmaceutical(Zhongshan)Inc. Ciclosporin Soft Capsules Product
 Table 129. Anshi Pharmaceutical(Zhongshan)Inc. Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Ciclosporin Soft Capsules Distributors List
 Table 133. Ciclosporin Soft Capsules Customers List
 Table 134. Ciclosporin Soft Capsules Market Trends
 Table 135. Ciclosporin Soft Capsules Market Drivers
 Table 136. Ciclosporin Soft Capsules Market Challenges
 Table 137. Ciclosporin Soft Capsules Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ciclosporin Soft Capsules
 Figure 2. Global Ciclosporin Soft Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ciclosporin Soft Capsules Market Share by Type: 2024 & 2031
 Figure 4. 10mg Product Picture
 Figure 5. 25mg Product Picture
 Figure 6. 50mg Product Picture
 Figure 7. Global Ciclosporin Soft Capsules Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Ciclosporin Soft Capsules Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Retail Pharmacy
 Figure 12. Others
 Figure 13. Global Ciclosporin Soft Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Ciclosporin Soft Capsules Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Ciclosporin Soft Capsules Sales (2020-2031) & (K Units)
 Figure 16. Global Ciclosporin Soft Capsules Average Price (US$/Unit) & (2020-2031)
 Figure 17. Ciclosporin Soft Capsules Report Years Considered
 Figure 18. Ciclosporin Soft Capsules Sales Share by Manufacturers in 2024
 Figure 19. Global Ciclosporin Soft Capsules Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Ciclosporin Soft Capsules Players: Market Share by Revenue in Ciclosporin Soft Capsules in 2024
 Figure 21. Ciclosporin Soft Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Ciclosporin Soft Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Ciclosporin Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 24. North America Ciclosporin Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 25. United States Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Ciclosporin Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 28. Europe Ciclosporin Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Ciclosporin Soft Capsules Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Ciclosporin Soft Capsules Revenue Market Share by Region (2020-2031)
 Figure 36. China Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Ciclosporin Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Ciclosporin Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Ciclosporin Soft Capsules Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Ciclosporin Soft Capsules Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Ciclosporin Soft Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Ciclosporin Soft Capsules by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Ciclosporin Soft Capsules by Type (2020-2031)
 Figure 55. Global Ciclosporin Soft Capsules Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Ciclosporin Soft Capsules by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Ciclosporin Soft Capsules by Application (2020-2031)
 Figure 58. Global Ciclosporin Soft Capsules Price (US$/Unit) by Application (2020-2031)
 Figure 59. Ciclosporin Soft Capsules Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Cyclosporine Drugs Market Research Report 2025
Global Ciclosporin Eye Drops Market Research Report 2024
Global Cyclosporine Eye Drop Market Research Report 2024
Global Tacrolimus Capsules Market Research Report 2024
Global Cyclosporin A Cyclosporin Market Research Report 2024
Global Ciclosporin Eye Drugs Market Research Report 2024
Global Soft Elastic Capsule Market Research Report 2024
Global Soft Capsules Market Research Report 2024
Global Cyclosporine Ophthalmic Emulsion Market Insights Forecast to 2030
Global Cyclosporine Ophthalmic Drugs Market Research Report 2024
Global Soft Capsule Technology Market Research Report 2024
Global Organ Transplant Immunosuppressant Drugs Market Insights Forecast to 2030
Global Cyclosporine Injection Market Research Report 2024
Global Organ Transplant Immunosuppressant Market Research Report 2024
Soft Capsules Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immunosuppressants Market Research Report 2024
Soft Gel Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cyclosporine API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tomato Soft Capsules Market Research Report 2024
Global Mini Softgel Capsule Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions